LTB4R and psoriasis: Research on a mouse model of psoriasis induced by imiquimod (IMQ) and intervened with Resolvin E1 (RvE1), a metabolite of omega-3 polyunsaturated fatty acids, has shown that RvE1 can terminate the inflammatory process by inhibiting Leukotriene B4 - BLT1(LTB4-BLT1) signaling and regulating the expression of Th17 and Tc17 cytokines, effectively inhibiting inflammatory cell infiltration and epidermal hyperplasia in psoriatic skin, thereby improving the severity of psoriasis (Sawada et al., 2018; Oner et al., 2021).